Daniella Beckman is the Chief Financial Officer at Tango Therapeutics Inc., a biotechnology company focused on precision oncology. With an extensive background in finance and strategic planning, Beckman has been instrumental in guiding Tango Therapeutics through its growth and development. Prior to joining Tango, she held various high-level financial positions at leading life sciences companies, where she honed her expertise in financial management and corporate strategy. Beckman's career is marked by significant achievements, including leading successful financings and IPOs that have enabled companies to advance their research and development efforts. At Tango Therapeutics, she oversees all financial operations, including budgeting, forecasting, and investor relations. Her strategic vision and financial acumen have been crucial in securing the resources needed to drive the company's innovative cancer therapies forward. In her role as CFO, Beckman plays a pivotal part in shaping Tango Therapeutics' future. She works closely with the executive team to ensure that the company's financial strategies align with its mission to transform cancer treatment. Her leadership and dedication to the company's goals have made her a respected figure in the biotechnology industry, and she continues to be a driving force behind Tango Therapeutics' success.